COVID-19 death | COVID-19 hospitalisation | |||
Females | Males | Females | Males | |
1 March 2020–30 April 2020 | ||||
R2 | 0.72 (0.71–0.73) | 0.69 (0.68–0.70) | 0.47 (0.46–0.49) | 0.48 (0.46–0.49) |
Royston’s D | 3.28 (3.20–3.37) | 3.06 (2.98–3.15) | 1.93 (1.87–2.00) | 1.96 (1.90–2.02) |
Harrell’s C | 0.95 (0.94–0.95) | 0.93 (0.92–0.93) | 0.81 (0.80–0.82) | 0.82 (0.81–0.82) |
Brier Score | 0.0022 (0.0008–0.0035) | 0.0043 (0.0031–0.0056) | 0.0011 (0.0009–0.0013) | 0.0021 (0.0017–0.0025) |
Observed-expected ratio | 1.94 | 1.55 | 1.13 | 1.04 |
1 May 2020–30 June 2020 | ||||
R2 | 0.75 (0.74–0.76) | 0.75 (0.73–0.76) | 0.47 (0.44–0.50) | 0.54 (0.51–0.57) |
Royston’s D | 3.56 (3.44–3.68) | 3.50 (3.37–3.63) | 1.92 (1.80–2.04) | 0.83 (0.82–0.85) |
Harrell’s C | 0.96 (0.95–0.96) | 0.95 (0.94–0.96) | 0.79 (0.78–0.81) | 0.83 (0.82–0.85) |
Brier Score | 0.0006 (0.0004–0.0009) | 0.0006 (0.0004–0.0008) | 0.0003 (0.0002–0.00036) | 0.0002 (0.0002–0.0002) |
Observed-expected ratio | 1.07 | 0.73 | 0.37 | 0.26 |
Observerved-expected ratios were calculated prior to recalibration in the second period. Brier scores were calculated after recalibration.